| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | somatostatin receptor activity | 1.15e-08 | 5 | 140 | 4 | GO:0004994 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 SSTR2 SSTR3 SSTR4 SSTR5 OR1J2 OR51E1 OR51D1 CELSR1 OR1L6 ADGRF4 CCR6 OR5H1 OR4F15 | 5.21e-08 | 884 | 140 | 23 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 FCRLA SSTR2 SSTR3 SSTR4 SSTR5 OR1J2 OR51E1 OR51D1 CELSR1 PLXNC1 PTPRZ1 PLXNA4 OR1L6 ADGRF4 CCR6 OR5H1 PLXNA2 OR4F15 | 1.93e-07 | 1353 | 140 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | neuropeptide binding | 5.74e-06 | 37 | 140 | 5 | GO:0042923 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 1.10e-05 | 431 | 140 | 13 | GO:0004984 |
| GeneOntologyMolecularFunction | calcium channel activity | 3.51e-05 | 129 | 140 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B DDX19A DNAH10 ATP10B IDE ABCA8 NLRP3 DNAH12 MDN1 ABCB8 NAV3 YME1L1 | 6.61e-05 | 441 | 140 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 7.09e-05 | 12 | 140 | 3 | GO:0005049 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 7.09e-05 | 12 | 140 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 9.54e-05 | 151 | 140 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.16e-04 | 14 | 140 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.46e-04 | 3 | 140 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 1.46e-04 | 3 | 140 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.55e-04 | 18 | 140 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.90e-04 | 4 | 140 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.01e-04 | 46 | 140 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DDX19A DNAH10 ATP10B IDE ARID1A ABCA8 NLRP3 DNAH12 MDN1 ABCB8 NAV3 YME1L1 | 3.91e-04 | 614 | 140 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C SCN11A KCNG3 SLC9C2 RYR1 RYR3 SLC30A6 CLCA3P CACNA1I CACNA1G MCOLN3 | 4.44e-04 | 465 | 140 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 4.81e-04 | 5 | 140 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.83e-04 | 52 | 140 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 5.19e-04 | 53 | 140 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1C SCN11A KCNG3 RYR1 RYR3 CLCA3P CACNA1I CACNA1G MCOLN3 | 7.16e-04 | 343 | 140 | 9 | GO:0005261 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 7.19e-04 | 6 | 140 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 7.79e-04 | 26 | 140 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX19B DDX19A RAN DNAH10 ATP10B IDE ABCA8 NLRP3 ARHGAP5 DNAH12 MDN1 ABCB8 NAV3 YME1L1 | 1.11e-03 | 775 | 140 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.31e-03 | 31 | 140 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 1.44e-03 | 32 | 140 | 3 | GO:0140142 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.58e-03 | 33 | 140 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1C SCN11A ATP10B KCNG3 SLC29A2 SLC9C2 ABCA8 RYR1 RYR3 SLC30A6 SLC35D1 SLC22A18 CLCA3P TMEM184A SLC50A1 ABCB8 CACNA1I CACNA1G MCOLN3 | 1.68e-03 | 1289 | 140 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | odorant binding | 2.02e-03 | 127 | 140 | 5 | GO:0005549 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.20e-03 | 37 | 140 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX19B DDX19A RAN DNAH10 ATP10B IDE ABCA8 NLRP3 ARHGAP5 DNAH12 MDN1 ABCB8 NAV3 YME1L1 | 2.33e-03 | 839 | 140 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX19B DDX19A RAN DNAH10 ATP10B IDE ABCA8 NLRP3 ARHGAP5 DNAH12 MDN1 ABCB8 NAV3 YME1L1 | 2.35e-03 | 840 | 140 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX19B DDX19A RAN DNAH10 ATP10B IDE ABCA8 NLRP3 ARHGAP5 DNAH12 MDN1 ABCB8 NAV3 YME1L1 | 2.35e-03 | 840 | 140 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.47e-03 | 133 | 140 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 3.09e-03 | 140 | 140 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1C SCN11A KCNG3 SLC29A2 SLC9C2 ABCA8 RYR1 RYR3 SLC30A6 SLC35D1 SLC22A18 CLCA3P SLC50A1 ABCB8 CACNA1I CACNA1G MCOLN3 | 3.74e-03 | 1180 | 140 | 17 | GO:0022857 |
| GeneOntologyBiologicalProcess | somatostatin receptor signaling pathway | 2.77e-08 | 6 | 137 | 4 | GO:0038169 | |
| GeneOntologyBiologicalProcess | somatostatin signaling pathway | 2.77e-08 | 6 | 137 | 4 | GO:0038170 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | SCN11A HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 SSTR2 SSTR3 SSTR4 SSTR5 NPVF ADCY6 PREX2 OR1J2 OR51E1 OR51D1 CELSR1 OR1L6 ADGRF4 CCR6 OR5H1 OR4F15 | 4.19e-07 | 1395 | 137 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 3.16e-06 | 61 | 137 | 6 | GO:0007187 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 6.34e-06 | 432 | 137 | 13 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | SCN11A OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 STRC OR5H1 OR4F15 | 7.79e-06 | 582 | 137 | 15 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 1.39e-05 | 465 | 137 | 13 | GO:0007608 |
| GeneOntologyBiologicalProcess | ribosomal large subunit export from nucleus | 1.57e-05 | 8 | 137 | 3 | GO:0000055 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 1.66e-05 | 81 | 137 | 6 | GO:0071384 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 2.16e-05 | 485 | 137 | 13 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus | SCN11A OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 NLRP3 OR51E1 OR51D1 OR1L6 STRC OR5H1 OR4F15 | 2.48e-05 | 722 | 137 | 16 | GO:0051606 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 3.21e-05 | 239 | 137 | 9 | GO:0071383 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 4.80e-05 | 524 | 137 | 13 | GO:0009593 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | RAN HTR2B GPER1 SSTR2 SSTR3 ARID1A SSTR4 SSTR5 ADCY6 RYR1 RYR3 EPG5 SCGB2A2 NODAL | 5.17e-05 | 605 | 137 | 14 | GO:0071407 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1C SCN11A HTR2B GPER1 HAP1 RYR1 RYR3 CLCA3P CACNA1I CACNA1G MCOLN3 | 6.33e-05 | 392 | 137 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | maintenance of location | CACNA1C MOSPD2 HTR2B GPER1 HAP1 TMEM135 ADCY6 FAF1 RYR1 RYR3 EPG5 | 6.93e-05 | 396 | 137 | 11 | GO:0051235 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 7.42e-05 | 547 | 137 | 13 | GO:0007606 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.30e-05 | 36 | 137 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.03e-04 | 217 | 137 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | ribosomal subunit export from nucleus | 1.51e-04 | 16 | 137 | 3 | GO:0000054 | |
| GeneOntologyBiologicalProcess | ribosome localization | 1.51e-04 | 16 | 137 | 3 | GO:0033750 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 1.62e-04 | 77 | 137 | 5 | GO:0060425 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 2.30e-04 | 244 | 137 | 8 | GO:0009755 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.40e-04 | 185 | 137 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 2.64e-04 | 133 | 137 | 6 | GO:0006939 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 4.09e-04 | 202 | 137 | 7 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 4.09e-04 | 202 | 137 | 7 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 4.22e-04 | 203 | 137 | 7 | GO:0035150 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 4.36e-04 | 146 | 137 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 4.52e-04 | 147 | 137 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 4.86e-04 | 149 | 137 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 5.59e-04 | 153 | 137 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1C SCN11A HTR2B GPER1 HAP1 RYR1 RYR3 CLCA3P CACNA1I CACNA1G MCOLN3 | 6.00e-04 | 509 | 137 | 11 | GO:0006816 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 8.01e-05 | 13 | 140 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.31e-04 | 73 | 140 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.87e-04 | 17 | 140 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | cation channel complex | 1.89e-04 | 235 | 140 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.53e-04 | 46 | 140 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | ooplasm | 6.56e-04 | 6 | 140 | 2 | GO:1990917 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.46e-04 | 29 | 140 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.03e-03 | 378 | 140 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex | 1.21e-03 | 8 | 140 | 2 | GO:0000506 | |
| Domain | Somatstn_rcpt | 1.34e-08 | 5 | 136 | 4 | IPR000586 | |
| Domain | GPCR_Rhodpsn_7TM | HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 SSTR2 SSTR3 SSTR4 SSTR5 OR1J2 OR51E1 OR51D1 OR1L6 CCR6 OR5H1 OR4F15 | 1.67e-08 | 670 | 136 | 21 | IPR017452 |
| Domain | 7tm_1 | HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 SSTR2 SSTR3 SSTR4 SSTR5 OR1J2 OR51E1 OR51D1 OR1L6 CCR6 OR5H1 OR4F15 | 2.00e-08 | 677 | 136 | 21 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 SSTR2 SSTR3 SSTR4 SSTR5 OR1J2 OR51E1 OR51D1 OR1L6 CCR6 OR5H1 OR4F15 | 2.44e-08 | 685 | 136 | 21 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 SSTR2 SSTR3 SSTR4 SSTR5 OR1J2 OR51E1 OR51D1 OR1L6 CCR6 OR5H1 OR4F15 | 2.84e-08 | 691 | 136 | 21 | PS50262 |
| Domain | GPCR_Rhodpsn | HTR2B GPER1 OR5D14 OR1S2 OR5AN1 MC3R OR5H15 OR1C1 OR5H14 OR6C65 SSTR2 SSTR3 SSTR4 SSTR5 OR1J2 OR51E1 OR51D1 OR1L6 CCR6 OR5H1 OR4F15 | 2.91e-08 | 692 | 136 | 21 | IPR000276 |
| Domain | Ion_trans_dom | 1.85e-06 | 114 | 136 | 8 | IPR005821 | |
| Domain | Ion_trans | 1.85e-06 | 114 | 136 | 8 | PF00520 | |
| Domain | Channel_four-helix_dom | 3.57e-06 | 57 | 136 | 6 | IPR027359 | |
| Domain | - | 3.57e-06 | 57 | 136 | 6 | 1.20.120.350 | |
| Domain | Olfact_rcpt | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 6.08e-06 | 393 | 136 | 13 | IPR000725 |
| Domain | Plexin_cytopl | 3.07e-05 | 9 | 136 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 3.07e-05 | 9 | 136 | 3 | IPR013548 | |
| Domain | Plexin | 3.07e-05 | 9 | 136 | 3 | IPR031148 | |
| Domain | VDCCAlpha1 | 4.37e-05 | 10 | 136 | 3 | IPR002077 | |
| Domain | AAA | 8.92e-05 | 144 | 136 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 8.92e-05 | 144 | 136 | 7 | IPR003593 | |
| Domain | ATPase_dyneun-rel_AAA | 1.30e-04 | 14 | 136 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.30e-04 | 14 | 136 | 3 | PF07728 | |
| Domain | Ryanodine_rcpt | 1.57e-04 | 3 | 136 | 2 | IPR003032 | |
| Domain | VDCC_T_a1 | 1.57e-04 | 3 | 136 | 2 | IPR005445 | |
| Domain | Ryanrecept_TM4-6 | 1.57e-04 | 3 | 136 | 2 | IPR009460 | |
| Domain | RyR | 1.57e-04 | 3 | 136 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.57e-04 | 3 | 136 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.57e-04 | 3 | 136 | 2 | IPR013333 | |
| Domain | 7TM_GPCR_Srsx | 1.70e-04 | 112 | 136 | 6 | SM01381 | |
| Domain | RIH_assoc-dom | 7.75e-04 | 6 | 136 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 7.75e-04 | 6 | 136 | 2 | PF08709 | |
| Domain | RIH_assoc | 7.75e-04 | 6 | 136 | 2 | PF08454 | |
| Domain | RIH_dom | 7.75e-04 | 6 | 136 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.75e-04 | 6 | 136 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.75e-04 | 6 | 136 | 2 | IPR015925 | |
| Domain | - | 7.75e-04 | 6 | 136 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.75e-04 | 6 | 136 | 2 | PF01365 | |
| Domain | IPT | 9.72e-04 | 27 | 136 | 3 | SM00429 | |
| Domain | Sec1-like | 1.43e-03 | 8 | 136 | 2 | IPR001619 | |
| Domain | Sec-1-like_dom2 | 1.43e-03 | 8 | 136 | 2 | IPR027482 | |
| Domain | Sec1 | 1.43e-03 | 8 | 136 | 2 | PF00995 | |
| Domain | - | 1.43e-03 | 8 | 136 | 2 | 3.40.50.1910 | |
| Domain | Semap_dom | 1.46e-03 | 31 | 136 | 3 | IPR001627 | |
| Domain | SEMA | 1.46e-03 | 31 | 136 | 3 | PS51004 | |
| Domain | TIG | 1.46e-03 | 31 | 136 | 3 | PF01833 | |
| Domain | Sema | 1.46e-03 | 31 | 136 | 3 | SM00630 | |
| Domain | Sema | 1.46e-03 | 31 | 136 | 3 | PF01403 | |
| Domain | IPT | 1.60e-03 | 32 | 136 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 1.60e-03 | 32 | 136 | 3 | IPR002165 | |
| Domain | PSI | 1.60e-03 | 32 | 136 | 3 | PF01437 | |
| Domain | MIR | 2.28e-03 | 10 | 136 | 2 | PF02815 | |
| Domain | MIR_motif | 2.28e-03 | 10 | 136 | 2 | IPR016093 | |
| Domain | MIR | 2.28e-03 | 10 | 136 | 2 | PS50919 | |
| Domain | MIR | 2.28e-03 | 10 | 136 | 2 | SM00472 | |
| Domain | HlyIII | 2.77e-03 | 11 | 136 | 2 | PF03006 | |
| Domain | AdipoR/HlyIII-related | 2.77e-03 | 11 | 136 | 2 | IPR004254 | |
| Domain | ARM-type_fold | 3.42e-03 | 339 | 136 | 8 | IPR016024 | |
| Domain | Rho_GTPase_activation_prot | 3.91e-03 | 88 | 136 | 4 | IPR008936 | |
| Domain | PSI | 4.02e-03 | 44 | 136 | 3 | IPR016201 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.52e-03 | 14 | 136 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 4.52e-03 | 14 | 136 | 2 | IPR013602 | |
| Domain | DHC_N2 | 4.52e-03 | 14 | 136 | 2 | PF08393 | |
| Domain | IMPORTIN_B_NT | 4.52e-03 | 14 | 136 | 2 | PS50166 | |
| Domain | AAA_8 | 4.52e-03 | 14 | 136 | 2 | PF12780 | |
| Domain | PSI | 4.56e-03 | 46 | 136 | 3 | SM00423 | |
| Domain | EF-hand-dom_pair | 5.10e-03 | 287 | 136 | 7 | IPR011992 | |
| Domain | DHC_fam | 5.19e-03 | 15 | 136 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 5.19e-03 | 15 | 136 | 2 | PF03028 | |
| Domain | IBN_N | 5.19e-03 | 15 | 136 | 2 | PF03810 | |
| Domain | Dynein_heavy_dom | 5.19e-03 | 15 | 136 | 2 | IPR004273 | |
| Domain | IBN_N | 5.91e-03 | 16 | 136 | 2 | SM00913 | |
| Domain | Importin-beta_N | 6.66e-03 | 17 | 136 | 2 | IPR001494 | |
| Domain | Ig_E-set | 7.06e-03 | 104 | 136 | 4 | IPR014756 | |
| Domain | EF_hand_dom | 7.10e-03 | 232 | 136 | 6 | IPR002048 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.44e-05 | 70 | 117 | 6 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 3.63e-05 | 75 | 117 | 6 | M39696 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5D14 OR1S2 OR5AN1 OR5H15 OR1C1 OR5H14 OR6C65 OR1J2 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 4.19e-05 | 417 | 117 | 13 | M4072 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 8.76e-05 | 11 | 117 | 3 | M47958 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.58e-04 | 186 | 117 | 8 | MM15994 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.14e-04 | 260 | 117 | 9 | M39397 | |
| Pathway | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | 3.48e-04 | 17 | 117 | 3 | MM14621 | |
| Pathway | WP_GPCRS_NONODORANT | 3.71e-04 | 266 | 117 | 9 | MM15843 | |
| Pathway | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | 4.15e-04 | 18 | 117 | 3 | M1093 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 4.90e-04 | 19 | 117 | 3 | M10959 | |
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 11897118 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 11753241 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 19330452 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 12414882 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 20717067 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 12021920 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 18936524 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 8449518 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 25962406 | ||
| Pubmed | Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors. | 1.29e-09 | 5 | 141 | 4 | 26474434 | |
| Pubmed | Somatostatin receptor subtypes in human type 2 diabetic islets. | 1.29e-09 | 5 | 141 | 4 | 20182388 | |
| Pubmed | Identification and characterization of a novel human cortistatin-like peptide. | 3.86e-09 | 6 | 141 | 4 | 9125122 | |
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 1346068 | ||
| Pubmed | Brain somatostatin receptors are up-regulated in somatostatin-deficient mice. | 3.86e-09 | 6 | 141 | 4 | 12145348 | |
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 19423539 | ||
| Pubmed | 8.97e-09 | 7 | 141 | 4 | 22581439 | ||
| Pubmed | 8.97e-09 | 7 | 141 | 4 | 25149275 | ||
| Pubmed | Null mutant mouse models of somatostatin and cortistatin, and their receptors. | 8.97e-09 | 7 | 141 | 4 | 18206294 | |
| Pubmed | 5.33e-08 | 10 | 141 | 4 | 16214911 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 21503779 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 11472428 | ||
| Pubmed | The expression of somatostatin receptors 3, 4 and 5 in laryngeal pathology. | 6.52e-08 | 3 | 141 | 3 | 18066572 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 17609435 | ||
| Pubmed | Somatostatin signaling in neuronal cilia is critical for object recognition memory. | 6.52e-08 | 3 | 141 | 3 | 20335466 | |
| Pubmed | Somatostatin receptors 3, 4 and 5 play important roles in gallbladder cancer. | 6.52e-08 | 3 | 141 | 3 | 23991955 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 9892014 | ||
| Pubmed | Somatostatin receptor subtype 4 couples to the M-current to regulate seizures. | 6.52e-08 | 3 | 141 | 3 | 18385315 | |
| Pubmed | Expression of somatostatin receptors 3, 4, and 5 in mouse kidney proximal tubules. | 6.52e-08 | 3 | 141 | 3 | 12472768 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5D14 OR1S2 OR5AN1 OR5H15 OR5H14 OR6C65 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 1.58e-07 | 340 | 141 | 11 | 11875048 |
| Pubmed | OR5D14 OR1S2 OR5AN1 OR5H15 OR5H14 OR6C65 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 1.58e-07 | 340 | 141 | 11 | 11802173 | |
| Pubmed | OR5D14 OR1S2 OR5AN1 OR5H15 OR5H14 OR6C65 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 1.72e-07 | 343 | 141 | 11 | 32295537 | |
| Pubmed | OR5D14 OR1S2 OR5AN1 OR5H15 OR5H14 OR6C65 OR51E1 OR51D1 OR1L6 OR5H1 OR4F15 | 1.88e-07 | 346 | 141 | 11 | 14611657 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 25808161 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 10996426 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 18256292 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.60e-07 | 38 | 141 | 5 | 30786075 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 11344221 | ||
| Pubmed | Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours. | 6.48e-07 | 5 | 141 | 3 | 9279525 | |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 12759718 | ||
| Pubmed | 7.58e-07 | 18 | 141 | 4 | 20810604 | ||
| Pubmed | UBR2 CNKSR2 FHIP1B ADCY6 EPG5 KLHL13 SPHKAP NAV3 HERC3 PLXNA2 XPO7 | 9.30e-07 | 407 | 141 | 11 | 12693553 | |
| Pubmed | Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. | 1.29e-06 | 6 | 141 | 3 | 9205124 | |
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 22419713 | ||
| Pubmed | DDX19B POLE MC3R MUC16 NBEA IDE ARID1A TRIM64C RYR1 DNAH12 MDN1 PPP2R3C YME1L1 | 2.18e-06 | 638 | 141 | 13 | 31182584 | |
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 15661641 | ||
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 11784029 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 3.60e-06 | 8 | 141 | 3 | 12761855 | |
| Pubmed | 3.61e-06 | 26 | 141 | 4 | 9226367 | ||
| Pubmed | 5.38e-06 | 9 | 141 | 3 | 16382099 | ||
| Pubmed | 7.67e-06 | 10 | 141 | 3 | 24778262 | ||
| Pubmed | 1.40e-05 | 12 | 141 | 3 | 19095005 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.40e-05 | 12 | 141 | 3 | 21270798 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25008035 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 26531719 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15118275 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12134013 | ||
| Pubmed | Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies. | 1.63e-05 | 2 | 141 | 2 | 24967740 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 9489997 | ||
| Pubmed | Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly. | 1.63e-05 | 2 | 141 | 2 | 15914528 | |
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 1.63e-05 | 2 | 141 | 2 | 12640042 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 26627919 | ||
| Pubmed | The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. | 1.63e-05 | 2 | 141 | 2 | 9837918 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14602773 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17272399 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14592949 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24182563 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 32585100 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25925002 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24026422 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25554089 | ||
| Pubmed | Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas. | 1.63e-05 | 2 | 141 | 2 | 22640914 | |
| Pubmed | Life of psi: how full-length HIV-1 RNAs become packaged genomes in the viral particles. | 1.63e-05 | 2 | 141 | 2 | 24530126 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 9799464 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 33704440 | ||
| Pubmed | The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA. | 1.63e-05 | 2 | 141 | 2 | 25486595 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25486594 | ||
| Pubmed | Loading and unloading: orchestrating centrosome duplication and spindle assembly by Ran/Crm1. | 1.63e-05 | 2 | 141 | 2 | 16294017 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15574331 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12210479 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19623609 | ||
| Pubmed | Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals. | 1.63e-05 | 2 | 141 | 2 | 28282025 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.63e-05 | 2 | 141 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 1.63e-05 | 2 | 141 | 2 | 11500519 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20233783 | ||
| Pubmed | Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. | 1.63e-05 | 2 | 141 | 2 | 9177396 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12565913 | ||
| Pubmed | CRM1 is an export receptor for leucine-rich nuclear export signals. | 1.63e-05 | 2 | 141 | 2 | 9323133 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 9192302 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10518602 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22651821 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 7556644 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 16954443 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 18653781 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 8373420 | ||
| Pubmed | Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality. | 1.63e-05 | 2 | 141 | 2 | 27986975 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15857828 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 1.63e-05 | 2 | 141 | 2 | 15894801 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19426801 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 18927079 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12372020 | ||
| Interaction | SST interactions | 1.97e-07 | 9 | 129 | 4 | int:SST | |
| Interaction | CORT interactions | 8.81e-06 | 21 | 129 | 4 | int:CORT | |
| Cytoband | 12q24.3 | 1.39e-04 | 6 | 141 | 2 | 12q24.3 | |
| Cytoband | Xp22.12 | 2.59e-04 | 8 | 141 | 2 | Xp22.12 | |
| Cytoband | 17q24 | 4.15e-04 | 10 | 141 | 2 | 17q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q11 | 6.27e-04 | 54 | 141 | 3 | chr3q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 8.04e-04 | 134 | 141 | 4 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 8.97e-04 | 138 | 141 | 4 | chr9q33 | |
| GeneFamily | Somatostatin receptors | 6.22e-09 | 5 | 109 | 4 | 257 | |
| GeneFamily | Plexins | 1.74e-05 | 9 | 109 | 3 | 683 | |
| GeneFamily | Olfactory receptors, family 1 | 9.66e-05 | 40 | 109 | 4 | 147 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.08e-04 | 3 | 109 | 2 | 287 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 2.62e-04 | 21 | 109 | 3 | 680 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.01e-04 | 26 | 109 | 3 | 253 | |
| GeneFamily | Olfactory receptors, family 5 | 5.84e-04 | 112 | 109 | 5 | 152 | |
| GeneFamily | Exportins | 7.42e-04 | 7 | 109 | 2 | 547 | |
| GeneFamily | Progestin and adipoQ receptor family | 1.91e-03 | 11 | 109 | 2 | 930 | |
| GeneFamily | Dyneins, axonemal | 4.62e-03 | 17 | 109 | 2 | 536 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 116 | 141 | 6 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.89e-06 | 194 | 141 | 7 | ea5b7727ffef6cb454c501979a51bc1d4108d0e4 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 158 | 141 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 158 | 141 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 158 | 141 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 1.21e-05 | 160 | 141 | 6 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-05 | 171 | 141 | 6 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.08e-05 | 176 | 141 | 6 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-05 | 180 | 141 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 2.44e-05 | 181 | 141 | 6 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.52e-05 | 182 | 141 | 6 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 2.59e-05 | 183 | 141 | 6 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 183 | 141 | 6 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 185 | 141 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 3.39e-05 | 192 | 141 | 6 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 192 | 141 | 6 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.49e-05 | 193 | 141 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.49e-05 | 193 | 141 | 6 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-05 | 193 | 141 | 6 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 194 | 141 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.81e-05 | 196 | 141 | 6 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.81e-05 | 196 | 141 | 6 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-05 | 197 | 141 | 6 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-05 | 197 | 141 | 6 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-05 | 199 | 141 | 6 | ec1e110671e7725f752163c7241dbbf638dec2b2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cbln1_(VTA_(dorsal_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 64 | 141 | 4 | 1b75c6ea17ba7efa83ffe8ae07a863abcdad542c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cbln1_(VTA_(dorsal_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 64 | 141 | 4 | 275b4c418dc631a0925d6516cee6bf217cb7240a | |
| Drug | Bim23268 | 4.59e-08 | 7 | 139 | 4 | CID005311026 | |
| Drug | Ee 581 | 9.14e-08 | 8 | 139 | 4 | CID003036100 | |
| Drug | BIM 23034 | 9.14e-08 | 8 | 139 | 4 | CID005492589 | |
| Drug | Somatostatin | 9.14e-08 | 8 | 139 | 4 | ctd:D013004 | |
| Drug | L-779,976 | 1.48e-07 | 21 | 139 | 5 | CID005311372 | |
| Drug | Tyr(3)-sms | 1.64e-07 | 9 | 139 | 4 | CID000123864 | |
| Drug | X Bb | 1.64e-07 | 9 | 139 | 4 | CID000445281 | |
| Drug | Seglitidum [latin] | 2.23e-07 | 3 | 139 | 3 | CID003035423 | |
| Drug | Edotreotide | 9.11e-07 | 13 | 139 | 4 | CID000158782 | |
| Drug | SRA 880 | 1.27e-06 | 14 | 139 | 4 | CID005311376 | |
| Drug | etorphine | 1.60e-06 | 59 | 139 | 6 | CID000026721 | |
| Drug | CNS 1145 | 1.63e-06 | 33 | 139 | 5 | CID000190902 | |
| Drug | IHC-64 | 1.63e-06 | 33 | 139 | 5 | CID000162753 | |
| Drug | L-817,818 | 1.72e-06 | 15 | 139 | 4 | CID005311375 | |
| Drug | L-796,778 | 2.29e-06 | 16 | 139 | 4 | CID005311373 | |
| Drug | Cycam | 3.81e-06 | 18 | 139 | 4 | CID000122080 | |
| Drug | L-803,087 | 3.81e-06 | 18 | 139 | 4 | CID005311374 | |
| Drug | pasireotide | 3.81e-06 | 18 | 139 | 4 | ctd:C517782 | |
| Drug | Zwittergent 3-12 | 3.81e-06 | 18 | 139 | 4 | CID000084703 | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | ZNF573 CNKSR2 SLC29A2 ADCY6 CSF1 PLXNC1 SCAPER CACNA1I CTDSPL | 3.82e-06 | 199 | 139 | 9 | 6295_UP |
| Drug | Lopac-S-1316 | 4.37e-06 | 40 | 139 | 5 | CID003086457 | |
| Drug | AC1O3HA7 | 4.39e-06 | 6 | 139 | 3 | CID006328526 | |
| Drug | AC1L1I54 | 4.95e-06 | 41 | 139 | 5 | CID000004426 | |
| Drug | LY215840 | 7.66e-06 | 7 | 139 | 3 | CID000132049 | |
| Drug | BIM-23027 | 7.66e-06 | 7 | 139 | 3 | CID005311025 | |
| Drug | Peptavlon | 8.32e-06 | 78 | 139 | 6 | CID000021701 | |
| Drug | ANB-NOS | 1.08e-05 | 23 | 139 | 4 | CID003080866 | |
| Drug | lanreotide | 1.22e-05 | 8 | 139 | 3 | ctd:C060347 | |
| Drug | NSC7524 | 1.65e-05 | 182 | 139 | 8 | CID000005657 | |
| Drug | butamifos | 1.79e-05 | 26 | 139 | 4 | CID000037419 | |
| Drug | Rc 121 | 1.79e-05 | 26 | 139 | 4 | CID000127388 | |
| Drug | Cinnarizine | 1.82e-05 | 9 | 139 | 3 | DB00568 | |
| Drug | AC1Q5JP2 | 1.82e-05 | 9 | 139 | 3 | CID000134288 | |
| Drug | Depreotide | 1.82e-05 | 9 | 139 | 3 | CID009898619 | |
| Drug | Cyclo Ss-8 | 1.82e-05 | 9 | 139 | 3 | CID003081285 | |
| Drug | Hexapeptide 4 | 1.82e-05 | 9 | 139 | 3 | CID000194954 | |
| Drug | eniluracil | 2.09e-05 | 27 | 139 | 4 | CID000043157 | |
| Drug | Cinildipine | 2.35e-05 | 56 | 139 | 5 | CID000002752 | |
| Drug | dtpa-sms | 2.43e-05 | 28 | 139 | 4 | CID000072128 | |
| Drug | ruthenium | 2.43e-05 | 94 | 139 | 6 | CID000023950 | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 2.71e-05 | 195 | 139 | 8 | 2790_UP | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 3374_UP | |
| Drug | isovalerate | 2.85e-05 | 143 | 139 | 7 | CID000010430 | |
| Drug | nitrendipine | 3.08e-05 | 98 | 139 | 6 | CID000004507 | |
| Drug | Tt 232 | 3.22e-05 | 30 | 139 | 4 | CID000164469 | |
| Drug | azathioprine, USP; Down 200; 100uM; MCF7; HG-U133A | 3.25e-05 | 200 | 139 | 8 | 338_DN | |
| Drug | nilvadipine | 3.29e-05 | 60 | 139 | 5 | CID000004494 | |
| Drug | isradipine | 3.46e-05 | 100 | 139 | 6 | CID000003784 | |
| Drug | Mibefradil | 3.54e-05 | 11 | 139 | 3 | DB01388 | |
| Drug | IAA-94 | 3.57e-05 | 61 | 139 | 5 | CID000003667 | |
| Drug | AN-201 | 3.68e-05 | 31 | 139 | 4 | CID000119196 | |
| Drug | 111In-pentetreotide | 3.68e-05 | 31 | 139 | 4 | CID003081912 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 3.70e-05 | 2 | 139 | 2 | ctd:C005147 | |
| Drug | lercanidipine | 4.17e-05 | 63 | 139 | 5 | CID000065866 | |
| Drug | AC1LA7UO | 4.19e-05 | 32 | 139 | 4 | CID000483172 | |
| Drug | CGS 8216 | 4.74e-05 | 33 | 139 | 4 | CID000104916 | |
| Drug | gallopamil | 5.62e-05 | 67 | 139 | 5 | CID000001234 | |
| Drug | dimefox | 6.01e-05 | 35 | 139 | 4 | CID000008264 | |
| Drug | N-carbamylglutamate | 6.09e-05 | 13 | 139 | 3 | CID000121396 | |
| Drug | AC1L2AC7 | 6.48e-05 | 69 | 139 | 5 | CID000068733 | |
| Drug | lamotrigine | 7.95e-05 | 116 | 139 | 6 | CID000003878 | |
| Drug | AC1NBU2S | 8.34e-05 | 117 | 139 | 6 | CID004473765 | |
| Drug | CAS 298-57-7 | 8.49e-05 | 73 | 139 | 5 | CID000002761 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.53e-05 | 170 | 139 | 7 | 3791_DN | |
| Drug | ethosuximide | 9.06e-05 | 74 | 139 | 5 | CID000003291 | |
| Drug | FPL 64176 | 9.60e-05 | 15 | 139 | 3 | CID000003423 | |
| Drug | TMB-8 | 1.06e-04 | 176 | 139 | 7 | CID000005494 | |
| Drug | Octreotide | 1.11e-04 | 3 | 139 | 2 | DB00104 | |
| Drug | cis-diammineplatinum(II | 1.11e-04 | 3 | 139 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.11e-04 | 3 | 139 | 2 | CID002750949 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 1.11e-04 | 3 | 139 | 2 | CID010679219 | |
| Drug | 8N3-cADPR | 1.11e-04 | 3 | 139 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.11e-04 | 3 | 139 | 2 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.11e-04 | 3 | 139 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.11e-04 | 3 | 139 | 2 | CID000080262 | |
| Drug | AN 238 | 1.11e-04 | 3 | 139 | 2 | ctd:C110845 | |
| Drug | flubendiamide | 1.11e-04 | 3 | 139 | 2 | CID011193251 | |
| Drug | Vapreotide | 1.11e-04 | 3 | 139 | 2 | DB04894 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.11e-04 | 3 | 139 | 2 | CID005748312 | |
| Drug | nisoldipine | 1.16e-04 | 78 | 139 | 5 | CID000004499 | |
| Drug | Verapamil | 1.18e-04 | 16 | 139 | 3 | DB00661 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.24e-04 | 79 | 139 | 5 | CID005287890 | |
| Drug | bepridil | 1.26e-04 | 126 | 139 | 6 | CID000002351 | |
| Drug | pimozide | 1.31e-04 | 127 | 139 | 6 | CID000016362 | |
| Drug | Zonisamide | 1.42e-04 | 17 | 139 | 3 | DB00909 | |
| Drug | lutetium | 1.49e-04 | 44 | 139 | 4 | CID000023929 | |
| Drug | Cabergoline-d5 | 1.56e-04 | 83 | 139 | 5 | CID000002512 | |
| Drug | lanthanum | 1.91e-04 | 136 | 139 | 6 | CID000023926 | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 5088_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 3767_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 6722_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 7052_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 4847_DN | |
| Drug | nifedipine; Down 200; 10uM; MCF7; HG-U133A | 2.13e-04 | 197 | 139 | 7 | 335_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 6310_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3413_UP | |
| Drug | verapamil | CACNA1C KCNG3 ABCA8 ADCY6 RYR1 RYR3 ABCB8 CACNA1I CACNA1G NODAL YME1L1 | 2.16e-04 | 490 | 139 | 11 | CID000002520 |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 3396_UP | |
| Drug | A-30 | 2.20e-04 | 4 | 139 | 2 | CID003028528 | |
| Drug | thsat | 2.20e-04 | 4 | 139 | 2 | CID000195015 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | blood pressure, response to thiazide, response to beta blocker | 6.03e-05 | 3 | 133 | 2 | EFO_0004325, EFO_0007766, EFO_0007981 | |
| Disease | Multiple congenital anomalies-hypotonia-seizures syndrome | 1.20e-04 | 4 | 133 | 2 | cv:C5191419 | |
| Disease | Klatskin's tumor (is_implicated_in) | 2.00e-04 | 5 | 133 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | Grand Mal Status Epilepticus | 2.43e-04 | 67 | 133 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.43e-04 | 67 | 133 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.43e-04 | 67 | 133 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.43e-04 | 67 | 133 | 4 | C0751523 | |
| Disease | Petit mal status | 2.43e-04 | 67 | 133 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.43e-04 | 67 | 133 | 4 | C0393734 | |
| Disease | Status Epilepticus | 2.57e-04 | 68 | 133 | 4 | C0038220 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 2.70e-04 | 28 | 133 | 3 | DOID:3717 (is_marker_for) | |
| Disease | Congenital Pain Insensitivity | 4.17e-04 | 7 | 133 | 2 | C0002768 | |
| Disease | neutrophil percentage of leukocytes | UBR2 MOSPD2 ARID1A FAF1 NLRP3 SLC35D1 MED24 MLXIPL GFOD1 PPP2R3C | 4.60e-04 | 610 | 133 | 10 | EFO_0007990 |
| Disease | Embryonal Rhabdomyosarcoma | 5.55e-04 | 8 | 133 | 2 | C0206656 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 7.44e-04 | 157 | 133 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Neuroendocrine Tumors | 1.08e-03 | 11 | 133 | 2 | C0206754 | |
| Disease | alcohol consumption measurement | PIGN CACNA1C TFAP2D NBEA KCNG3 FAF1 RASIP1 MLXIPL SPHKAP SCAPER PLXNA4 CACNA1I PLXNA2 XPO7 | 1.47e-03 | 1242 | 133 | 14 | EFO_0007878 |
| Disease | estradiol measurement | 1.57e-03 | 110 | 133 | 4 | EFO_0004697 | |
| Disease | Ciliopathies | 1.57e-03 | 110 | 133 | 4 | C4277690 | |
| Disease | bone fracture | 1.68e-03 | 112 | 133 | 4 | EFO_0003931 | |
| Disease | endometrial carcinoma | 1.74e-03 | 113 | 133 | 4 | EFO_1001512 | |
| Disease | triglycerides in medium VLDL measurement | 1.98e-03 | 55 | 133 | 3 | EFO_0022155 | |
| Disease | triglycerides in large VLDL measurement | 2.08e-03 | 56 | 133 | 3 | EFO_0022178 | |
| Disease | Antibody Deficiency Syndrome | 2.62e-03 | 17 | 133 | 2 | C0003257 | |
| Disease | triglycerides in small VLDL measurement | 2.66e-03 | 61 | 133 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 2.66e-03 | 61 | 133 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 2.79e-03 | 62 | 133 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 2.79e-03 | 62 | 133 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.79e-03 | 62 | 133 | 3 | EFO_0022299 | |
| Disease | Tourette syndrome, schizophrenia | 2.94e-03 | 18 | 133 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | cholesterol in large VLDL measurement | 3.19e-03 | 65 | 133 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.19e-03 | 65 | 133 | 3 | EFO_0022230 | |
| Disease | total lipids in large VLDL | 3.47e-03 | 67 | 133 | 3 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 3.62e-03 | 68 | 133 | 3 | EFO_0022327 | |
| Disease | susceptibility to chronic sinus infection measurement | 3.62e-03 | 68 | 133 | 3 | EFO_0008419 | |
| Disease | free cholesterol in large VLDL measurement | 3.62e-03 | 68 | 133 | 3 | EFO_0022265 | |
| Disease | amino acid measurement | 3.70e-03 | 678 | 133 | 9 | EFO_0005134 | |
| Disease | stomach cancer (is_marker_for) | 3.97e-03 | 142 | 133 | 4 | DOID:10534 (is_marker_for) | |
| Disease | triglycerides to total lipids in small HDL percentage | 4.26e-03 | 72 | 133 | 3 | EFO_0022336 | |
| Disease | lymphocyte count, response to vaccine | 4.39e-03 | 22 | 133 | 2 | EFO_0004587, EFO_0004645 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFDFQLRNSNMSIIC | 396 | Q7L0X2 | |
| EEICLLTTFAQMAQA | 771 | Q9HCE0 | |
| DSCNQTTLQMLLEIF | 351 | P41595 | |
| ALTECFEIMTVDFNN | 366 | Q6P2P2 | |
| LLVFTSAIANMFTCN | 751 | O43306 | |
| QATMICCLVFFLSTE | 6 | Q8IZF3 | |
| SEMLLCSLQEVRQFS | 31 | P51684 | |
| NFDSFVACMIRLETL | 661 | A6NHC0 | |
| LFNCTTISFVDLRAM | 2101 | Q9NYQ6 | |
| IDSNSCFEIQLLSFM | 156 | P0CG01 | |
| ADFFLALTICNSVMV | 581 | O94823 | |
| ICAALSTFQTVLSEM | 391 | Q7Z6R9 | |
| LLDEVIMCTFQQSVY | 691 | Q5U651 | |
| IQAQCAIIMFDVTSR | 81 | P62826 | |
| MISLSECKIQFFSIA | 91 | A6NDH6 | |
| LFSFATFNEMCTLLI | 201 | Q8NGL3 | |
| TACILSLFQMTNETL | 36 | Q9NXK6 | |
| CVAMAIFSALSQLLE | 331 | Q8TAE7 | |
| ACTDTQFLELMAFLL | 186 | A6NJZ3 | |
| MTNVFLDRVFQECLT | 306 | Q969Q6 | |
| LMNSLVSQVICDVLF | 2266 | O14497 | |
| ALLSFAFICVTDQMT | 631 | P0C881 | |
| ALLSFAFICVTDQMT | 631 | B2RC85 | |
| ALALFMSSLEFCNAV | 296 | Q8N612 | |
| TFRFCLVTNLTMDSV | 14246 | Q8WXI7 | |
| MISLSECKIQLFSFA | 91 | A6NHG9 | |
| KLSCSDIFLNELVMF | 186 | Q8NGS2 | |
| NIFQEALDCFTAMLS | 571 | Q9NU22 | |
| VLCSMTNTYEVLEFL | 191 | Q9H2X6 | |
| FRSLNMVSECLFSLI | 441 | Q8TDD5 | |
| TCFQQESLDVSQMIL | 726 | Q9NVR5 | |
| LNVQEFCTAIAFLMA | 451 | P59045 | |
| SMILEQILNSFESCL | 476 | Q15034 | |
| ITDACLSVVAQTFMD | 1766 | O75051 | |
| ITDACLSVVAQTFMD | 1766 | Q9HCM2 | |
| CLSVIAQAFMDAFSL | 1441 | O60486 | |
| SLFLMGIQEIEFNIC | 96 | Q8NGF3 | |
| STTIQFDACLLQMFA | 91 | Q8TCB6 | |
| SQMIENVDVCLSFLA | 136 | Q8IVL0 | |
| FNICSINSFSDETMV | 2026 | Q6ZR08 | |
| TVDFMRTDNTCVNLL | 256 | Q9P2J3 | |
| YLNLDTCLSQAFEMS | 1636 | Q07864 | |
| SESQLAVFCEVLTMQ | 256 | P23471 | |
| FLLANLSIIDMAFCS | 61 | Q8NGB8 | |
| RLACTNTQELEFMVT | 186 | Q8NGB8 | |
| LDCVLSSFQMTNETV | 36 | Q6TCH4 | |
| LDSNELCQFIMTTFD | 336 | Q9H579 | |
| LCQFIMTTFDTLKTL | 341 | Q9H579 | |
| LILSCTDTFFVQVMT | 186 | Q8NGI8 | |
| NTFGMCVLQDFEALT | 116 | Q9H0A0 | |
| SCSDTMINELVLFIV | 201 | Q8NGQ3 | |
| MISLSECKIQFFSFA | 91 | A6NKK0 | |
| MLTFCQLFTKVEVEF | 271 | Q7L5N7 | |
| RQADMLSQTDCFVSL | 81 | Q3MJ16 | |
| IIQLFATCFLASLMF | 16 | Q9BYG0 | |
| FILTISQQFSECMDL | 136 | Q6EBC2 | |
| FMRTDNTCVNLLLEA | 301 | Q9P2N7 | |
| SLSIQRFVCEMTNLQ | 941 | Q8NCX0 | |
| NIVIVTTLLQFMFAC | 1051 | Q13936 | |
| DSQMETSCQITFEFV | 56 | P09603 | |
| NCEDILMNFLVSAVT | 651 | Q16394 | |
| MINLCLVVIATQFSE | 386 | O43497 | |
| QRMGQLFECVLFTAS | 156 | O15194 | |
| VAQMLLAASFETLQC | 21 | Q7L513 | |
| SFFMINLCLVVIATQ | 386 | Q9P0X4 | |
| ILEICNVVFTSMFAL | 671 | Q9P0X4 | |
| QMLILECVEQFSEAS | 346 | P54257 | |
| RNCQMLLFSATFEDS | 266 | Q9UMR2 | |
| FNTYLVLIMCNSVID | 281 | P41968 | |
| STSENMFLELFCQII | 801 | P14735 | |
| LTNVFCSQMLCAESI | 386 | Q9UNN5 | |
| NCQMLLFSATFEDSV | 266 | Q9NUU7 | |
| DQCFVFVSMNLDLLA | 481 | Q9BRP7 | |
| NRLIVLCIENSFMTD | 1371 | P39059 | |
| DMFNVNVLALSICTR | 116 | Q6UWP2 | |
| DLQQICEIMLFSEGF | 1961 | Q8IVF4 | |
| SDFQVCMEILNTYLT | 4051 | Q8IVF4 | |
| EQEMSCVLLATFIQD | 1336 | Q9BY12 | |
| FCEDTIFEMQIAAQI | 4236 | P21817 | |
| ITEMTDYCLQDLSNL | 131 | Q6UXK5 | |
| QLSCSDVSFNVMIIF | 186 | Q15619 | |
| LSNIAFNCMVLGTLF | 381 | Q9NUT2 | |
| FVDLCSMSNISVFLL | 766 | Q5HYA8 | |
| SNLSFMDICFTTVIV | 101 | Q8NGR2 | |
| EQCSRFFSLVKEMIT | 611 | Q6ZN16 | |
| FSLIQENEVLFTMCF | 396 | Q96P20 | |
| ILQYENSIMLCTDVS | 256 | Q96J94 | |
| INSIDMDFVRFIINC | 156 | Q8NHP6 | |
| MESTNQLLLDVICFT | 706 | Q2M3C7 | |
| RINLEACSNEMVTFL | 101 | Q7RTN6 | |
| MASVCFINSFSAVLQ | 131 | Q14542 | |
| NQFTSIFCLTVMSVD | 126 | P32745 | |
| GIRQITSDDFCTFQM | 211 | Q9NXC2 | |
| DSCLERFQMDLFTVT | 126 | Q96S42 | |
| NFIICVEMLFASVAL | 306 | Q6ZMB5 | |
| LEMNFIIQDAESITC | 106 | Q8NFP9 | |
| IAVLCTFMSLFLQVN | 126 | Q99527 | |
| ELLYSIFCLDMQQVT | 766 | O75448 | |
| EMQSLQIAAFLFTVC | 301 | Q9H0W8 | |
| DGLNMFTSVFCLTVL | 126 | P31391 | |
| IMNSDCLVFDTSIAQ | 251 | Q8IUQ4 | |
| FNVNIETCFTALVQM | 231 | Q13017 | |
| ADTLFLLQFTLSCVM | 251 | Q9NTN3 | |
| MTLDGVNQFTSVFCL | 116 | P35346 | |
| NCFLSDISDTLFTMT | 246 | Q9NP71 | |
| QFTSIFCLTVMSIDR | 126 | P30874 | |
| SCEFLQQINSMVDFL | 1196 | Q7RTU9 | |
| VLAATELTCLFMQFS | 31 | Q96BI1 | |
| NLIVATNFMLAFDTC | 396 | O94911 | |
| DIFMENSLIQQCTSF | 551 | P53675 | |
| MISATFCDSQLRLLF | 1046 | Q15021 | |
| SIVFMQNLDSVTEFC | 236 | Q9Y6N3 | |
| QMYLDLFLDICQNTT | 991 | Q8WXI2 | |
| LNTSLTEAFCMAIVE | 306 | P37287 | |
| QIFDAVFECTLNMIN | 821 | O14980 | |
| MTCFQELVTFRDVAI | 21 | Q86YE8 | |
| MEQTFRSAEQITALC | 1051 | Q8IVF5 | |
| TSNIFCADELVMSNL | 21 | Q9HCQ7 | |
| CLINFKEFSSAIDIM | 876 | Q0IIM8 | |
| VNFCEDTIFEMQLAS | 4086 | Q15413 | |
| LQQLGLFCSVFTISM | 126 | Q9BRV3 | |
| TAICFQAAVMEVQTL | 386 | Q86UB9 | |
| FTLCENSMILSAAIF | 56 | Q14442 | |
| LNFITLEDDMFVLCN | 151 | Q8WVM8 | |
| LVATVCAFSEQLMAA | 1271 | Q70Z35 | |
| QDICFVLLALNMSSQ | 521 | O43548 | |
| LVMCAFEAVQLTTQL | 841 | O95427 | |
| RMLLNFCSIFDLSSE | 961 | Q9BQI6 | |
| NVEVFMQLIYDSSLC | 76 | Q13296 | |
| DVQTLAMLCSVFEAQ | 741 | Q6PJI9 | |
| ECMFSDFLTKLNIVS | 56 | Q96TA2 | |
| TFVALCFNLFTMLSI | 141 | Q6NXT4 | |
| TLVEAVSMSALECQF | 81 | O14904 | |
| QMLSTVLNIIIFEDC | 981 | Q9UIA9 | |
| SIVALLSFADVMNCV | 646 | Q9UI33 | |
| NCTDIIFTHIFILEM | 1091 | Q9UI33 | |
| CILADVFSNMLTNII | 241 | Q5TAH2 | |
| MTLLFSFAQAVACAE | 166 | P37837 | |
| TQETLLCMACVFEVS | 396 | P28347 | |
| MICTKNAELTISFFL | 2241 | Q9BXT5 | |
| MDSDTLRVFQNELIC | 1 | A6NLI5 | |
| NEMETFGATFVLVLC | 401 | Q9P2L0 | |
| LICLFQENSEIMNSL | 1556 | Q8IWV8 | |
| VRLLNCSDFAFTDMT | 541 | Q9H267 | |
| SFLTAASFLQMQCVI | 101 | Q8NCN2 | |
| LAACSTFMRDQFLLT | 51 | Q15916 |